Who Paid My Doc
Eclipse Treatment Planning System for External Beam Radiation Therapy
Device Oncology
PDI 00855141006035
General payments
$471,682
Research payments
$8,205,868
Through program year 2025, $471,682 in general payments and $8,205,868 in research payments were reported against Eclipse Treatment Planning System for External Beam Radiation Therapy (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $62,031 | 89 |
| 2025 | Research | $2,461,439 | 31 |
| 2024 | General | $133,405 | 52 |
| 2024 | Research | $2,254,429 | 44 |
| 2023 | General | $85,321 | 79 |
| 2023 | Research | $1,440,437 | 26 |
| 2022 | General | $103,331 | 128 |
| 2022 | Research | $635,364 | 16 |
| 2021 | General | $87,593 | 47 |
| 2021 | Research | $1,414,199 | 25 |
Breakdown
The top 5 of 74 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
395 general · 142 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.